Abstract

Objective To knockdown the C-erbB2 gene in salivary gland adenoid cystic carcinoma SACC-83 cells using RNA interference, and determine the effect of silencing C-erbB2 on cell proliferation. Methods C-erbB2-siRNA was transfected into SACC-83 cells. RT-PCR and immunohistochemistry were used to detect C-erbB2 expression in SACC-83 cells. Cell proliferation was measured by the MTT assay and gene knockdown was achieved by RNA interference. Apoptosis was analyzed by flow cytometry. Results Compared with the control, C-erbB2 mRNA expression was decreased in the C-erbB2-siRNA transfection group, and immunohistochemical analysis indicated that C-erbB2 protein expression was decreased. After C-erbB2-siRNA was transfected for 48 h, absorbance at 570 nm (MTT) was 0.185 ± 0.021 compared with 0.354 ± 0.034, 0.299 ± 0.053, and 0.314 ± 0.049 in the blank control, liposome control and negative control siRNA groups, respectively. The differences were statistically significant ( P < 0.05) between the C-erbB2-siRNA group and the control groups. Following the C-erbB2 knockdown, the percentage of apoptotic cells was 5.63% compared with 2.04%, 2.85%, and 2.98% in the three control groups, respectively. Proliferation of SACC-83 cells was inhibited, and early apoptotic cells were increased. Conclusion RNA interference can effectively silence C-erbB2 gene expression and inhibit growth of SACC-83 cells, which indicates the potential of targeting this gene as a novel gene therapy approach for the treatment of salivary gland adenoid cystic carcinoma.

Highlights

  • Salivary gland adenoid cystic carcinoma (SACC) is one of the most biologically destructive and unpredictable of the oral and maxillofacial tumours and it is extremely difficult to treat[1,2,3,4,5]

  • Adenoid cystic carcinoma is a malignant neoplasm of the salivary glands

  • The tumour which has a significant propensity for perineural spread and distant metastasis is associated with a high mortality rate and often recurs after prolonged periods of time

Read more

Summary

INTRODUCTION

Salivary gland adenoid cystic carcinoma (SACC) is one of the most biologically destructive and unpredictable of the oral and maxillofacial tumours and it is extremely difficult to treat[1,2,3,4,5]. Current therapies of SACC are surgery, chemotherapy and radiotherapy[6,7,8]. Gene therapy is a subject of current studies of potential tumour biology therapy[9,10,11,12,13]. The study of oncogene expression and function is

MATERIALS AND METHODS
Design target sequence of siRNA
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call